Compare REI & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REI | APYX |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.3M | 169.6M |
| IPO Year | 2013 | 1995 |
| Metric | REI | APYX |
|---|---|---|
| Price | $1.26 | $3.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | ★ 6.4M | 230.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,178,072.00 | N/A |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | $10.17 | $11.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $1.41 |
| 52 Week High | $2.00 | $4.50 |
| Indicator | REI | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 51.75 |
| Support Level | $1.22 | $3.18 |
| Resistance Level | $1.64 | $4.29 |
| Average True Range (ATR) | 0.09 | 0.37 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 0.91 | 66.22 |
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.